Home » Stocks » Johnson & Johnson

Johnson & Johnson (JNJ)

Stock Price: $144.44 USD 0.23 (0.16%)
Updated Sep 23, 2020 4:00 PM EDT - Market closed
Pre-market: $145.00 +0.56 (0.39%) Sep 24, 5:49 AM

Stock Price Chart

Key Info

Market Cap 380.28B
Revenue (ttm) 80.50B
Net Income (ttm) 15.19B
Shares Out 2.63B
EPS (ttm) 5.68
PE Ratio 25.43
Forward PE 16.23
Dividend $4.04
Dividend Yield 2.80%

Stock Quote

Trading Day Sep 23, 2020
Last Price $144.44
Previous Close $144.21
Change ($) 0.23
Change (%) 0.16%
Day's Open 147.48
Day's Range 144.38 - 147.55
Day's Volume 5,295,917
52-Week Range 109.16 - 157.00

More Stats

Market Cap 380.28B
Enterprise Value 391.54B
Earnings Date (est) Oct 13, 2020
Ex-Dividend Date Aug 24, 2020
Shares Outstanding 2.63B
Float 2.63B
EPS (basic) 5.78
EPS (diluted) 5.68
FCF / Share 6.63
Dividend $4.04
Dividend Yield 2.80%
Earnings Yield 3.93%
FCF Yield 4.59%
Payout Ratio n/a
Shares Short 10.56M
Short Ratio 1.96
Short % of Float 0.40%
Beta 0.68
PE Ratio 25.43
Forward PE 16.23
P/FCF Ratio 21.80
PS Ratio 4.72
PB Ratio 6.15
Revenue 80.50B
Operating Income 19.84B
Net Income 15.19B
Free Cash Flow 17.44B
Net Cash -11.26B
Net Cash / Share -4.28
Gross Margin 67.83%
Operating Margin 24.64%
Profit Margin 18.90%
FCF Margin 21.67%
ROA 8.05%
ROE 24.54%
ROIC 30.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (17)

Buy 10
Overweight 2
Hold 4
Underweight 1
Sell 0

Analyst Consensus: Buy

Price Target

(14.14% upside)
Current: $144.44
Target: 164.87
*Average 12-month price target from 15 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth0.59%6.71%6.34%2.59%-5.73%4.23%6.08%3.37%5.59%-
Gross Profit54,50354,49051,01150,10148,53851,58548,97045,56644,67042,795
Operating Income19,81419,79818,18020,37117,55620,95918,37715,86915,58416,527
Net Income15,11915,2971,30016,54015,40916,32313,83110,8539,67213,334
Shares Outstanding2,6452,6822,6922,7372,7722,8152,8092,7532,7362,751
Earnings Per Share5.635.610.475.935.485.704.813.863.494.78
EPS Growth0.36%1093.62%-92.07%8.21%-3.86%18.5%24.61%10.6%-26.99%-
Dividend Per Share3.753.543.323.152.952.762.592.402.252.11
Dividend Growth5.93%6.63%5.4%6.78%6.88%6.56%7.92%6.67%6.64%-
Operating Cash Flow23,41622,20121,05618,76719,56918,71017,41415,39614,29816,385
Capital Expenditures-3,498-3,670-3,279-3,226-3,463-3,714-3,595-2,934-2,893-2,384
Free Cash Flow19,91818,53117,77715,54116,10614,99613,81912,46211,40514,001
Cash & Equivalents19,28719,68718,29641,90738,37633,08929,20621,08932,26127,658
Total Debt27,69630,48034,58127,12619,86118,76018,18016,16519,62716,773
Net Cash / Debt-8,409-10,793-16,28514,78118,51514,32911,0264,92412,63410,885
Book Value59,47159,75260,16070,41871,15069,75274,05364,82657,08056,579
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Johnson & Johnson
Country United States
Employees 132,200
CEO Alex Gorsky

Stock Information

Ticker Symbol JNJ
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Drug Manufacturers—General
Unique Identifier NYSE: JNJ


Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.